Therapeutic Applications
Therapeutic Applications - Related Videos
09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
0 Views •
Cited by 17 •
2016
We present a protocol for the synthesis of RGD-functionalized hydrogels as devices for cell and drug delivery. The procedure involves copper catalyzed alkyne-azide cycloaddition (CuAAC) between alkyne-modified polyacrylic acid (PAA) and a RGD-azide derivative. The hydrogels are formed using microwave-assisted polycondensation and their physicochemical properties are investigated.
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
0 Views •
Cited by 2 •
2017
This protocol describes the in vitro comparison of two key functional characteristics of rituximab: target binding and complement-dependent cytotoxicity (CDC) induction. The methods were employed for a side-to-side comparison between reference rituximab and a rituximab biosimilar. These assays can be employed during biosimilar development or as a quality control in their production.
01:13
Therapeutic Index
0 Views •
2025
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
0 Views •
Cited by 5 •
2022
The present protocol describes the differential centrifugation for isolating and characterizing representative EVs (exosomes and microvesicles) from cultured human MSCs. Further applications of these EVs are also explained in this article.
FAQs
A medicine’s mechanism helps predict the biological change it can produce and the condition it may address. Receptor binding can modify signaling, enzyme inhibition can alter biochemical pathways, ion-channel modulation can change cellular activity, and replacement therapy can restore a deficient substance. Linking these actions to symptoms and disease processes supports more rational treatment choices.
Pharmacokinetics describes how drug exposure relates to effects over time, helping determine how long an effect may last. Dose-response relationships show how changing the dose can influence therapeutic outcomes and safety. Considering both factors allows pharmacologists to connect drug amounts with expected benefit, duration, and the risk of unwanted effects.
The mechanism of action provides a basis for anticipating outcomes such as symptom relief, disease control, or prevention of complications. A treatment that modifies a relevant receptor, enzyme, ion channel, or deficient substance may produce a different clinical result from one acting through another pathway. This mechanistic link helps interpret whether therapy is achieving its intended purpose.
Rational selection connects the medicine’s mechanism with pharmacokinetics, dose-response behavior, expected outcomes, and safety considerations. Clinicians and pharmacologists use these relationships to develop individualized treatment plans rather than treating drug choice as separate from patient response. The same framework also helps identify adverse effects and decide whether the selected approach remains appropriate.
Evaluation focuses on whether treatment produces meaningful outcomes, including symptom relief, disease control, or prevention of complications, while also considering duration and safety. Pharmacological knowledge links the drug’s action and dose-response behavior with the patient’s observed response. This connection supports assessment of benefits, recognition of adverse effects, and refinement of the treatment plan.
Studying therapeutic applications reveals how drug mechanisms, exposure over time, dose, benefits, and adverse effects relate to one another. These relationships help identify approaches that preserve useful clinical effects while improving safety. In pharmacology, this evidence supports the development of more effective therapies and informs individualized decisions about treatment selection and dosing.